Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication

Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication

Abstract Background Flares of juvenile idiopathic arthritis (JIA) have been described in the context of various infections. Flares of rheumatic diseases in adults have been described following infection with SARS-CoV-2 in several cohorts. So far, the effect of infection with SARS-CoV-2 on the course...

Full description

Bibliographic Details
Main Authors:	Boris Hügle, Manuela Krumrey-Langkammerer, Johannes-Peter Haas
Format:	Article
Language:	English
Published:	BMC 2021-11-01
Series:	Pediatric Rheumatology Online Journal
Online Access:	https://doi.org/10.1186/s12969-021-00653-8

Similar Items

IL-6 blockade in systemic juvenile idiopathic arthritis – achievement of inactive disease and remission (data from the German AID-registry)
by: M. Bielak, et al.
Published: (2018-04-01)

Treatment preferences in juvenile idiopathic arthritis – a comparative analysis in two health care systems
by: Hugle Boris, et al.
Published: (2013-01-01)

Agreement between objective and subjective definitions of inactive disease, remission and minimal disease activity in juvenile idiopathic arthritis
by: Davì S, et al.
Published: (2011-09-01)

α2-fraction and haptoglobin as biomarkers for disease activity in oligo- and polyarticular juvenile idiopathic arthritis
by: Ludwig Zeller, et al.
Published: (2022-08-01)

Education and employment in patients with juvenile idiopathic arthritis – a standardized comparison to the German general population
by: Jenny Schlichtiger, et al.
Published: (2017-05-01)

Treatment preferences in juvenile idiopathic arthritis – a comparative analysis in two health care systems
by: Hugle Boris, et al.
Published: (2011-09-01)

Long-Term Health-Related Quality of Life in German Patients with Juvenile Idiopathic Arthritis in Comparison to German General Population.
by: Swaantje Barth, et al.
Published: (2016-01-01)

Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing – treatment protocol and preliminary results
by: Lea Höfel, et al.
Published: (2018-02-01)

Inactive disease and remission rates after intraarticular steroids as initial therapy for juvenile idiopathic arhtritis (JIA)
by: Brito RG, et al.
Published: (2011-09-01)

Can remission be in juvenile idiopathic arthritis without the use of biological agents?
by: S. I. Valieva, et al.
Published: (2019-09-01)

Discontinuation of etanercept after clinical remission in patients with juvenile idiopathic arthritis
by: Cohen Jean-David, et al.
Published: (2012-07-01)

Mitigated suppressive function of regulatory T cells (Treg) upon Th17-inducing cytokines in oligo- and polyarticular Juvenile Idiopathic Arthritis (JIA) patients
by: Marie-Therese Holzer, et al.
Published: (2022-04-01)

Subclinical cardiovascular risk signs in adults with juvenile idiopathic arthritis in sustained remission
by: Inmaculada Concepción Aranda-Valera, et al.
Published: (2020-07-01)

Articular Doppler ultrasonography in juvenile idiopathic arthritis in remission: a prospective study
by: Natour Jamil, et al.
Published: (2011-09-01)

Patients with juvenile idiopathic arthritis in clinical remission with positive power Doppler signal in joint ultrasonography have an increased rate of clinical flare: a prospective study
by: Vanessa Bugni Miotto e Silva, et al.
Published: (2017-11-01)

Implications of SARS-CoV-2 Infection in Systemic Juvenile Idiopathic Arthritis
by: Laura Marinela Ailioaie, et al.
Published: (2022-04-01)

Idiopathic pulmonary hemosiderosis: Hemorrhagic flare after 6 years of remission
by: P. Silva, et al.
Published: (2017-11-01)

Juvenile idiopathic arthritis flare due to rice bodies in the knee of a 10yearold girl
by: G Faller, et al.
Published: (2018-10-01)

Uveitis Is a Risk Factor for Juvenile Idiopathic Arthritis' Significant Flare in Patients Treated With Biologics
by: Mikhail M. Kostik, et al.
Published: (2022-06-01)

Causes of invalidity in patients with juvenile idiopathic arthritis
by: T A Slielepina
Published: (2005-04-01)

Investigation of Inactive Disease States Among Patients With Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry
by: Melissa L. Mannion, et al.
Published: (2022-09-01)

Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis
by: Nicolino Ruperto, et al.
Published: (2022-03-01)

Causes of uveitis in children without juvenile idiopathic arthritis
by: Engelhard SB, et al.
Published: (2015-06-01)

Juvenile Idiopathic Arthritis
by: Kenan Barut, et al.
Published: (2017-04-01)

Juvenile Idiopathic Arthritis
by: Aleksandra Strońska, et al.
Published: (2021-08-01)

Juvenile idiopathic arthritis
by: Krupa H Bhatt, et al.
Published: (2014-01-01)

Correction: Intraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry
by: Timothy Hahn, et al.
Published: (2022-12-01)

Immunoprofiling of active and inactive systemic juvenile idiopathic arthritis reveals distinct biomarkers: a single-center study
by: Heshuang Qu, et al.
Published: (2021-12-01)

Clinical remission and subsequent relapse in patients with juvenile idiopathic arthritis: predictive factors according to therapeutic approach
by: Mireia Castillo-Vilella, et al.
Published: (2021-08-01)

Consenso em reumatologia pediátrica: parte I - definição dos critérios de doença inativa e remissão em artrite idiopática juvenil/artrite reumatóide juvenil Consensus in pediatric rheumatology: part I - criteria definition of inactive disease and remission in juvenile idiopathic arthritis / juvenile rheumatoid arthritis
by: Claudia Machado, et al.
Published: (2005-02-01)

Placeholder TextIntraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry
by: Timothy Hahn, et al.
Published: (2022-11-01)

Haptoglobin in Juvenile Idiopathic Arthritis
by: Lillemor Berntson, et al.
Published: (2022-12-01)

Juvenile Idiopathic Arthritis and Exercise
by: Pınar Kısacık, et al.
Published: (2016-04-01)

Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis
by: Guillaume Morelle, et al.
Published: (2021-03-01)

Screening for juvenile idiopathic arthritis associated uveitis with laser flare photometry in the pediatric rheumatology office: a prospective observational study
by: Kaleo Ede, et al.
Published: (2024-01-01)

Fused Omics Data Models Reveal Gut Microbiome Signatures Specific of Inactive Stage of Juvenile Idiopathic Arthritis in Pediatric Patients
by: Pamela Vernocchi, et al.
Published: (2020-10-01)

A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis
by: Cecilia Bava, et al.
Published: (2019-07-01)

Single-cell insights into immune dysregulation in rheumatoid arthritis flare versus drug-free remission
by: Kenneth F. Baker, et al.
Published: (2024-02-01)

Comparison of the accuracy of different definitions of clinical remission (CR) and minimal disease activity (MDA) in juvenile idiopathic arthritis (JIA)
by: Davì S, et al.
Published: (2008-09-01)

Seroprevalence of Antibodies against SARS-CoV-2 in Children with Juvenile Idiopathic Arthritis a Case-Control Study
by: Violetta Opoka-Winiarska, et al.
Published: (2021-04-01)